Dong-A ST’s ‘DA-9803’ transferred to U.S. NeuroBo

The Korea Drug Development Fund(President Hyun-Sang Mook, KDDF) announced the ‘Development of DA-9803, Natural Drug for the Treatment of Alzheimer’s Disease’ project that Dong-A ST has carried out has been transferred to U.S. NeuroBo Pharmaceuticals.

Dong-A ST’s ‘DA-9803,’ a medication for the treatment of Alzheimer’s disease which inhibits Amyloid beta(Aβ) and tau and raise a sense of cogniti...